Clincosm LogoSign in Get a demo

Plasma Cell Myeloma

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Cell Myeloma Trial in Worldwide (Isatuximab SAR650984, Bortezomib, Lenalidomide)

Active, not recruiting
  • Plasma Cell Myeloma
  • Isatuximab SAR650984
  • +3 more
  • Fort Myers, Florida
  • +103 more
Nov 3, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Plasma Cell Myeloma Trial in Worldwide (isatuximab SAR650984, Pomalidomide, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • isatuximab SAR650984
  • +3 more
  • Little Rock, Arkansas
  • +83 more
Aug 12, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Breast Tumor, Colorectal Tumor, Female Reproductive System Tumor Trial in Houston (Best Practice, Educational Intervention,

Active, not recruiting
  • Breast Neoplasm
  • +5 more
  • Best Practice
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Elotuzumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Plasma Cell Myeloma Trial in Puerto Rico, United States (Bortezomib, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Anchorage, Alaska
  • +919 more
Dec 29, 2021

After Whole Brain Radiation Therapy for Hematologic Malignancies

Recruiting
  • Central Nervous System Lymphoma
  • +5 more
  • Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 12, 2021

B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 6, 2021

Bone Sarcoma, Femur Fracture, Lymphoma Trial in Houston (Dalteparin)

Completed
Has Results
  • Bone Sarcoma
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2020

Plasma Cell Myeloma Trial in Houston (procedure, biological, drug)

Recruiting
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2020